Phase II study of TP300 in patients with advanced gastric or gastro-oesophageal junction adenocarcinoma

Por Propper, David, Jones, Keith, Anthoney, D. Alan, Mansoor, Wasat, Ford, Daniel, Eatock, Martin, Agarwal, Roshan, Inatani, Michiyasu, Saito, Tomohisa, Abe, Masaichi, Evans, T. R. Jeffry
Publicado no BMC Cancer (2016)

Switchable CAR-T cells mediate remission in metastatic pancreatic ductal adenocarcinoma

Por Raj, Deepak, Yang, Ming-Hsin, Rodgers, David, Hampton, Eric N, Begum, Julfa, Mustafa, Arif, Lorizio, Daniela, Garces, Irene, Propper, David, Kench, James G, Kocher, H M, Young, Travis S, Aicher, Alexandra, Heeschen, Christopher
Publicado no Gut (2019)

Analysis of colorectal cancers in British Bangladeshi identifies early onset, frequent mucinous histotype and a high prevalence of RBFOX1 deletion

Por Sengupta, Neel, Yau, Christopher, Sakthianandeswaren, Anuratha, Mouradov, Dmitri, Gibbs, Peter, Suraweera, Nirosha, Cazier, Jean-Baptiste, Polanco-Echeverry, Guadalupe, Ghosh, Anil, Thaha, Mohamed, Ahmed, Shafi, Feakins, Roger, Propper, David, Dorudi, Sina, Sieber, Oliver, Silver, Andrew, Lai, Cecilia
Publicado em 2013

Remodelling of microRNAs in colorectal cancer by hypoxia alters metabolism profiles and 5-fluorouracil resistance

Por Nijhuis, Anke, Thompson, Hannah, Adam, Julie, Parker, Alexandra, Gammon, Luke, Lewis, Amy, Bundy, Jacob G., Soga, Tomoyoshi, Jalaly, Aisha, Propper, David, Jeffery, Rosemary, Suraweera, Nirosha, McDonald, Sarah, Thaha, Mohamed A., Feakins, Roger, Lowe, Robert, Bishop, Cleo L., Silver, Andrew
Publicado no Hum Mol Genet (2017)

A phase I trial of the γ-secretase inhibitor MK-0752 in combination with gemcitabine in patients with pancreatic ductal adenocarcinoma

Por Cook, Natalie, Basu, Bristi, Smith, Donna-Michelle, Gopinathan, Aarthi, Evans, Jeffry, Steward, William P, Palmer, Daniel, Propper, David, Venugopal, Balaji, Hategan, Mirela, Anthoney, D Alan, Hampson, Lisa V, Nebozhyn, Michael, Tuveson, David, Farmer-Hall, Hayley, Turner, Helen, McLeod, Robert, Halford, Sarah, Jodrell, Duncan
Publicado no Br J Cancer (2018)

Intermittent versus continuous oxaliplatin and fluoropyrimidine combination chemotherapy for first-line treatment of advanced colorectal cancer: results of the randomised phase 3 M...

Por Adams, Richard A, Meade, Angela M, Seymour, Matthew T, Wilson, Richard H, Madi, Ayman, Fisher, David, Kenny, Sarah L, Kay, Edward, Hodgkinson, Elizabeth, Pope, Malcolm, Rogers, Penny, Wasan, Harpreet, Falk, Stephen, Gollins, Simon, Hickish, Tamas, Bessell, Eric M, Propper, David, Kennedy, M John, Kaplan, Richard, Maughan, Timothy S
Publicado em 2011

The VAR2CSA malaria protein efficiently retrieves circulating tumor cells in an EpCAM-independent manner

Por Agerbæk, Mette Ø., Bang-Christensen, Sara R., Yang, Ming-Hsin, Clausen, Thomas M., Pereira, Marina A., Sharma, Shreya, Ditlev, Sisse B., Nielsen, Morten A., Choudhary, Swati, Gustavsson, Tobias, Sorensen, Poul H., Meyer, Tim, Propper, David, Shamash, Jonathan, Theander, Thor G., Aicher, Alexandra, Daugaard, Mads, Heeschen, Christopher, Salanti, Ali
Publicado no Nat Commun (2018)

Phase I clinical trial repurposing all-trans retinoic acid as a stromal targeting agent for pancreatic cancer

Por Kocher, Hemant M., Basu, Bristi, Froeling, Fieke E. M., Sarker, Debashis, Slater, Sarah, Carlin, Dominic, deSouza, Nandita M., De Paepe, Katja N., Goulart, Michelle R., Hughes, Christine, Imrali, Ahmet, Roberts, Rhiannon, Pawula, Maria, Houghton, Richard, Lawrence, Cheryl, Yogeswaran, Yathushan, Mousa, Kelly, Coetzee, Carike, Sasieni, Peter, Prendergast, Aaron, Propper, David J.
Publicado no Nat Commun (2020)

Relative telomere lengths in tumor and normal mucosa are related to disease progression and chromosome instability profiles in colorectal cancer

Por Suraweera, Nirosha, Mouradov, Dmitri, Li, Shan, Jorissen, Robert N., Hampson, Debbie, Ghosh, Anil, Sengupta, Neel, Thaha, Mohamed, Ahmed, Shafi, Kirwan, Michael, Aleva, Floor, Propper, David, Feakins, Roger M., Vulliamy, Tom, Elwood, Ngaire J., Tian, Pei, Ward, Robyn L., Hawkins, Nicholas J., Xu, Zheng-Zhou, Molloy, Peter L., Jones, Ian T., Croxford, Matthew, Gibbs, Peter, Silver, Andrew, Sieber, Oliver M.
Publicado no Oncotarget (2016)

3 versus 6 months of adjuvant oxaliplatin-fluoropyrimidine combination therapy for colorectal cancer (SCOT): an international, randomised, phase 3, non-inferiority trial

Por Iveson, Timothy J, Kerr, Rachel S, Saunders, Mark P, Cassidy, Jim, Hollander, Niels Henrik, Tabernero, Josep, Haydon, Andrew, Glimelius, Bengt, Harkin, Andrea, Allan, Karen, McQueen, John, Scudder, Claire, Boyd, Kathleen Anne, Briggs, Andrew, Waterston, Ashita, Medley, Louise, Wilson, Charles, Ellis, Richard, Essapen, Sharadah, Dhadda, Amandeep S, Harrison, Mark, Falk, Stephen, Raouf, Sherif, Rees, Charlotte, Olesen, Rene K, Propper, David, Bridgewater, John, Azzabi, Ashraf, Farrugia, David, Webb, Andrew, Cunningham, David, Hickish, Tamas, Weaver, Andrew, Gollins, Simon, Wasan, Harpreet S, Paul, James
Publicado no Lancet Oncol (2018)

SCOT: a comparison of cost-effectiveness from a large randomised phase III trial of two durations of adjuvant Oxaliplatin combination chemotherapy for colorectal cancer

Por Robles-Zurita, José, Boyd, Kathleen A., Briggs, Andrew H., Iveson, Timothy, Kerr, Rachel S., Saunders, Mark P., Cassidy, Jim, Hollander, Niels Henrik, Tabernero, Josep, Segelov, Eva, Glimelius, Bengt, Harkin, Andrea, Allan, Karen, McQueen, John, Pearson, Sarah, Waterston, Ashita, Medley, Louise, Wilson, Charles, Ellis, Richard, Essapen, Sharadah, Dhadda, Amandeep S., Hughes, Rob, Falk, Stephen, Raouf, Sherif, Rees, Charlotte, Olesen, Rene K, Propper, David, Bridgewater, John, Azzabi, Ashraf, Farrugia, David, Webb, Andrew, Cunningham, David, Hickish, Tamas, Weaver, Andrew, Gollins, Simon, Wasan, Harpreet S, Paul, James
Publicado no Br J Cancer (2018)

3-month versus 6-month adjuvant chemotherapy for patients with high-risk stage II and III colorectal cancer: 3-year follow-up of the SCOT non-inferiority RCT.

Por Iveson, Timothy, Boyd, Kathleen A, Kerr, Rachel S, Robles-Zurita, Jose, Saunders, Mark P, Briggs, Andrew H, Cassidy, Jim, Hollander, Niels Henrik, Tabernero, Josep, Haydon, Andrew, Glimelius, Bengt, Harkin, Andrea, Allan, Karen, McQueen, John, Pearson, Sarah, Waterston, Ashita, Medley, Louise, Wilson, Charles, Ellis, Richard, Essapen, Sharadah, Dhadda, Amandeep S, Harrison, Mark, Falk, Stephen, Raouf, Sherif, Rees, Charlotte, Olesen, Rene K, Propper, David, Bridgewater, John, Azzabi, Ashraf, Farrugia, David, Webb, Andrew, Cunningham, David, Hickish, Tamas, Weaver, Andrew, Gollins, Simon, Wasan, Harpreet, Paul, James
Publicado no Health Technol Assess (2019)